ArticleJMA journal2022

Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer.

Rintaro On et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.